HIGHLIGHTS
- who: Anders Lund Selli from the Department of Medical Biology, Experimental and Clinical Pharmacology, u2013 The Arctic University of, Troms have published the Article: Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia, in the Journal: (JOURNAL)
- what: This study shows that pentoxifylline has minimal temperature-dependent pharmacodynamic changes and that it can inhibit elimination of both cAMP and cGMP at low temperatures.
- how: The unselective PDE-inhibitor pentoxifylline was investigated to determine its ability to reach the intracelu2011 lular space inhibit PDE3 and PDE5 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.